Please upgrade your browser.
TLN-4601, a small molecule derived from a nonpathogenic microorganism and TLN-232, a peptide used for the treatment of multiple oncology indications such as metastatic melanoma, renal cell carcinoma, and pancreatic cancer.
The National Institute for health and Clinical Excellence has turned down the drug called everolimus, also known as Afinitor, saying it does not offer enough benefit to patients to justify the cost.
Multilocular cystic renal cell carcinoma is an uncommon low grade renal cell carcinoma with unique morphologic features. Its cytogenetic characteristics have not been fully investigated. Its relationship to typical clear cell renal cell carcinoma is uncertain.
1H NMR based metabonomic approach was applied in order to monitor the alterations of plasma metabolic profile in Renal Cell Carcinoma (RCC) patients and controls
Treatment of Transitional Cell Cancer of the Renal Pelvis and Ureter in India at an Incredible Success Rate
Indian surgeons provide treatment of Transitional cell cancer of the renal pelvis and ureter with the best standards of Indian private healthcare system that can be truly described as being state-of-the-art.
MDOUTLOOK®, the oncology intelligence initiative powered by The Arcas Group, today announced results from its 3rd Annual Quick Poll research launched following this month's annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Within one week, 281 cancer treaters from 22 countries responded, making it the first market feedback available post-ASCO.
A new probe by the British scientists into the commonest form of kidney cancer have unveiled a batch of new gene mutations linked to it, suggesting even this apparently "straightforward" cancer type can be divided into subtypes requiring tailored treatment.
The company is providing a preliminary update on Trial 103 (the first stage of the Phase II program) in which MGCD265 is administered in combination with either erlotinib (Tarceva®) or docetaxel (Taxotere®) in solid tumor patients.
Kidney problems are the second serious condition linked to the cancer drug. Last year it was found that some patients on Avastin were at elevated risk of intestinal perforations.
Longtime Howard County football coach Ken Hovet died Monday night after fighting kidney cancer for several months. He was 49.
|Powered by NeonCRM|